Safety, Pharmacokinetic and -Dynamic Study of PR-15, an Inhibitor of Platelet Adhesion

NCT01042964 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Thrombosis
Acute Coronary Syndrome
Myocardial Infarction
Stroke

Interventions

DRUG: revacept (PR-15)

Sponsor

AdvanceCor GmbH

Collaborators

[object Object]